GGrantIndex
← Leaderboards

Shana O Kelley

Scripps Research Institute

Google Scholar ↗PubMed ↗ORCID ↗
$8,818,416
Attributed
$10,971,430
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,971,430 · 15

By mechanism

R01$8,518,554 · 7
R21$1,610,193 · 5
R33$823,606 · 1
F32$19,076 · 1
R13$1 · 1

Top collaborators

Most similar at Scripps Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsMolecularPerformanceProteinsTechnologyBiologicalValidationExhibitsCommunitiesResearch PersonnelTumorSpecificitySeriesMultidisciplinaryGenesMonitorScreeningGenome-WideNew TechnologyPhenotypeCell SeparationMicrofluidicsEngineeringDevices

Grant awards (39)

Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers$751,345
R01 · FY2025 · HL · contact PI
Engineering high performing microfluidic system for rapid non-invasive isolation and expansion of circulating tumor-reactive lymphocytes$637,371
R01 · FY2025 · CA · contact PI
A microfluidic platform for high performance sorting of immune cells based on their distinct secretion patterns$634,881
R01 · FY2025 · AI · contact PI
Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators$625,914
R01 · FY2025 · CA · contact PI
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy$239,392
R01 · FY2025 · CA · contact PI
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers$745,727
R01 · FY2024 · HL · contact PI
Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators$594,619
R01 · FY2024 · CA · contact PI
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy$249,479
R01 · FY2024 · CA · contact PI
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers$769,745
R01 · FY2023 · HL · contact PI
Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators$625,914
R01 · FY2023 · CA · contact PI
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy$259,550
R01 · FY2023 · CA · contact PI
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy$268,031
R01 · FY2022 · CA · contact PI
Development and Deployment of an Electrochemical Antigen Testing System for SARS-CoV-2$295,888
R21 · FY2021 · EB · contact PI
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy$212,579
R01 · FY2021 · CA · contact PI
Functional genetic screening to elucidate novel mitochondrial DNA repair factors using organelle-targeted chemical probes$183,600
R01 · FY2020 · GM · contact PI
2020 Liquid Biopsy for Cancer Gordon Research Conference and Seminar$1
R13 · FY2020 · CA · contact PI
Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis$305,702
R33 · FY2019 · CA · contact PI
Functional genetic screening to elucidate novel mitochondrial DNA repair factors using organelle-targeted chemical probes$183,600
R01 · FY2019 · GM · contact PI
Programmable electrochemical gene circuit sensors for infectious disease detection$150,164
R21 · FY2019 · AI · contact PI
Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis$258,952
R33 · FY2018 · CA · contact PI
Functional genetic screening to elucidate novel mitochondrial DNA repair factors using organelle-targeted chemical probes$183,600
R01 · FY2018 · GM · contact PI
Programmable electrochemical gene circuit sensors for infectious disease detection$150,214
R21 · FY2018 · AI · contact PI
Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis$258,952
R33 · FY2017 · CA · contact PI
Functional genetic screening to elucidate novel mitochondrial DNA repair factors using organelle-targeted chemical probes$183,600
R01 · FY2017 · GM · contact PI
Development of DNA-templated IR quantum dots$108,000
R21 · FY2009 · CA · contact PI
Development of DNA-templated IR quantum dots$129,600
R21 · FY2008 · CA · contact PI
Human Mitochondrial tRNA Structure and Function$199,878
R01 · FY2006 · GM · contact PI
Nanoscale Electrocatalytic Protein Detection$105,462
R21 · FY2006 · CA · contact PI
Nanoscale Electrocatalytic Protein Detection$45,407
R21 · FY2006 · CA · contact PI
Human Mitochondrial tRNA Structure and Function$226,740
R01 · FY2005 · GM
Nanoscale Electrocatalytic Protein Detection$154,500
R21 · FY2005 · CA
Human Mitochondrial tRNA Structure and Function$247,936
R01 · FY2004 · GM
Human Mitochondrial tRNA Structure and Function$246,332
R01 · FY2003 · GM
Detection of H. pylori using electrical DNA sensing$227,942
R21 · FY2003 · CA
Detection of H. pylori using electrical DNA sensing$15,000
R21 · FY2003 · CA
Human Mitochondrial tRNA Structure and Function$10,628
R01 · FY2003 · GM
Human Mitochondrial tRNA Structure and Function$238,093
R01 · FY2002 · GM
Detection of H. pylori using electrical DNA sensing$228,016
R21 · FY2002 · CA
ASSEMBLY OF AN AMINOACYLATING RIBONUCLEOPROTEIN$19,076
F32 · FY2000 · GM